Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schweiter Technologies is a Swiss industrial group focused on the composites and core materials business through its primary subsidiary, 3A Composites. The company develops and manufactures high-quality, lightweight materials used in architecture, visual communication, and various industrial markets including wind energy and transportation. Although not a pharmaceutical or biotech firm, Schweiter serves the healthcare industry by providing specialized composite materials for medical equipment, such as radiolucent components for imaging systems. The group is listed on the SIX Swiss Exchange and operates a global manufacturing and distribution network. Its portfolio includes well-known brands such as Alucobond, Airex, and Baltek.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schweiter Technologies.